Wall Street’s major market averages seesawed back and forth on Friday and finished mixed as Federal Reserve Governor ...

Eli Lilly will buy Boston-based Verve Therapeutics, Inc. in a billion dollar deal with plans to advance Verve's new line of ...

A cyberattack on Synnovis has been linked to a patient's death at King's College Hospital, marking a serious hacking ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/ ...

Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.

A new study from UCLA Health suggests COVID-19 vaccines may protect patients from severe kidney damage. The study found ...

At 12 weeks, weight loss ranged from 2.6% to 11.3%, compared to a gain of 0.2% in the placebo group. Guggenheim analysts were ...

The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially increased the demand for ...

Eli Lilly has tapped Camurus in a deal worth up to $870 million for its drug delivery technology to ... Alvotech and Dr. Reddy’s entered into a Collaboration to Co-Develop Biosimilar Candidate to ...

When Eli Lilly snapped up Scorpion Therapeutics' PI3Kα program earlier this year, the deal allowed Scorpion to spin out a new entity that would house its preclinical pipeline. | Antares may be forging ...

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

We have recently begun acquiring a new position in Novo Nordisk. Click here for our investment thesis on NVO stock.